This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board to approve September 2026 quarterly and half-year results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 1.4 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board will meet on November 4, 2026 to approve unaudited financial results for the quarter and half year ended September 30, 2026. The trading window is closed for promoters, directors, senior managers and their relatives, and will reopen 48 hours after the results become public.
This is only a meeting notice with no earnings figures, so it provides no clear signal for the stock until the results are published.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹63.99 Cr | ₹32.86 Cr | +94.7% |
| Operating profit | ₹1.26 Cr | ₹0.51 Cr | +145.1% |
| Profit after tax | ₹1.54 Cr | ₹1.54 Cr | +0.3% |
| EBITDA margin | 4.9% | 8.2% | −3.3 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.